Fabio
114 lines
8.3 KiB
Markdown
114 lines
8.3 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Prescription drug rebates and pricing."
|
||
description: "Requires a pharmacy benefit manager to provide a report to the department of insurance at least every six months. Provides that the report must include the: (1) overall aggregate amount charged to a health plan for all pharmaceutical claims processed by the pharmacy benefit manager; and (2) overall aggregate amount paid to pharmacies for claims processed by the pharmacy benefit manager. Requires that, for individual health insurance coverage, the defined cost sharing for a prescription drug be calculated at the point of sale and based on a price that is reduced by an amount equal to at least 85% of all rebates in connection with the dispensing or administration of the prescription drug. Requires that, for group health insurance coverage, an insurer: (1) pass through to a plan sponsor 100% of all rebates concerning the dispensing or administration of prescription drugs to the covered individuals of the plan sponsor; (2) provide a plan sponsor, at the time of contracting, the option of calculating defined cost sharing for covered individuals of the plan sponsor at the point of sale based on a price that is reduced by some or all of the rebates received concerning the dispensing or administration of the prescription drug; and (3) disclose specified information to the plan sponsor. Allows the department of insurance to enforce the provisions and impose a civil penalty."
|
||
jurisdiction: "us/states/in"
|
||
legislature: "Indiana General Assembly"
|
||
session: "2023"
|
||
identifier: "SB 8"
|
||
citation: "Indiana SB 8 (2023)"
|
||
classification: ["bill"]
|
||
subjects: ["HEALTH", "Health Care Costs; Health Insurance", "HEALTH", "Health Care Reform"]
|
||
status: "enacted"
|
||
primary_sponsors: ["Donna Schaibley", "Ed Charbonneau", "Mike Bohacek", "Vaneta Becker"]
|
||
version_count: 6
|
||
action_count: 42
|
||
vote_count: 1
|
||
first_action: "2023-01-09"
|
||
last_action: "2023-05-04"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/89871f11-3d5a-4b95-ad2d-86d752a9e5ac"
|
||
source_url: "http://iga.in.gov/legislative/2023/bills/senate/8"
|
||
source_hash: "cadd04387a24cddffdb67f64d176ab47d6bc8841a943ee85f09cd94eb1adb762"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-in"]
|
||
---
|
||
|
||
# Indiana SB 8 (2023) — Prescription drug rebates and pricing.
|
||
|
||
Requires a pharmacy benefit manager to provide a report to the department of insurance at least every six months. Provides that the report must include the: (1) overall aggregate amount charged to a health plan for all pharmaceutical claims processed by the pharmacy benefit manager; and (2) overall aggregate amount paid to pharmacies for claims processed by the pharmacy benefit manager. Requires that, for individual health insurance coverage, the defined cost sharing for a prescription drug be calculated at the point of sale and based on a price that is reduced by an amount equal to at least 85% of all rebates in connection with the dispensing or administration of the prescription drug. Requires that, for group health insurance coverage, an insurer: (1) pass through to a plan sponsor 100% of all rebates concerning the dispensing or administration of prescription drugs to the covered individuals of the plan sponsor; (2) provide a plan sponsor, at the time of contracting, the option of calculating defined cost sharing for covered individuals of the plan sponsor at the point of sale based on a price that is reduced by some or all of the rebates received concerning the dispensing or administration of the prescription drug; and (3) disclose specified information to the plan sponsor. Allows the department of insurance to enforce the provisions and impose a civil penalty.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Engrossed Senate Bill (H)** (committee substitute) — [source](http://in-proxy.openstates.org/2023/bills/SB0008/versions/SB0008.05.ENGH)
|
||
2. **Engrossed Senate Bill (S)** (committee substitute) — [source](http://in-proxy.openstates.org/2023/bills/SB0008/versions/SB0008.03.ENGS)
|
||
3. **Enrolled Senate Bill (S)** (committee substitute) — [source](http://in-proxy.openstates.org/2023/bills/SB0008/versions/SB0008.06.ENRH)
|
||
4. **Introduced Senate Bill (S)** (committee substitute) — [source](http://in-proxy.openstates.org/2023/bills/SB0008/versions/SB0008.01.INTR)
|
||
5. **Senate Bill (H)** (committee substitute) — [source](http://in-proxy.openstates.org/2023/bills/SB0008/versions/SB0008.04.COMH)
|
||
6. **Senate Bill (S)** (committee substitute) — [source](http://in-proxy.openstates.org/2023/bills/SB0008/versions/SB0008.02.COMS)
|
||
|
||
## Votes
|
||
|
||
- SB 8 - Charbonneau - 3rd Reading — **42–5** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- Donna Schaibley — primary (person)
|
||
- Ed Charbonneau — primary (person)
|
||
- Mike Bohacek — primary (person)
|
||
- Vaneta Becker — primary (person)
|
||
- Brad Barrett — cosponsor (person)
|
||
- Gregory Porter — cosponsor (person)
|
||
- Julie Olthoff — cosponsor (person)
|
||
- Justin Busch — coauthor (person)
|
||
- Lonnie Randolph — coauthor (person)
|
||
- Michael Crider — coauthor (person)
|
||
- Stacey Donato — coauthor (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2023-01-09** Authored by Senator Charbonneau
|
||
- **2023-01-09** First reading: referred to Committee on Health and Provider Services `reading-1, referral-committee`
|
||
- **2023-01-30** Senator Bohacek added as second author
|
||
- **2023-01-30** Senator Becker added as third author
|
||
- **2023-02-13** Senator Busch added as coauthor
|
||
- **2023-02-14** Senators Donato and Johnson added as coauthors
|
||
- **2023-02-16** Committee report: do pass, adopted `committee-passage`
|
||
- **2023-02-16** Senator Crider added as coauthor
|
||
- **2023-02-20** Amendment #1 (Charbonneau) prevailed; voice vote `amendment-passage`
|
||
- **2023-02-20** Second reading: amended, ordered engrossed `reading-2`
|
||
- **2023-02-21** Senator Randolph added as coauthor
|
||
- **2023-02-23** Third reading: passed; Roll Call 153: yeas 42, nays 5 `passage, reading-3, reading-3`
|
||
- **2023-02-23** House sponsor: Representative Schaibley
|
||
- **2023-02-23** Cosponsor: Representative Barrett
|
||
- **2023-02-24** Referred to the House `referral`
|
||
- **2023-02-28** First reading: referred to Committee on Insurance `reading-1, referral-committee`
|
||
- **2023-03-13** Representative Olthoff added as cosponsor
|
||
- **2023-04-06** Committee report: amend do pass, adopted `committee-passage`
|
||
- **2023-04-11** Amendment #1 (Schaibley) prevailed; voice vote `amendment-passage`
|
||
- **2023-04-11** Representative Porter added as cosponsor
|
||
- **2023-04-11** Second reading: amended, ordered engrossed `reading-2`
|
||
- **2023-04-12** Third reading: passed; Roll Call 406: yeas 94, nays 0 `passage, reading-3, reading-3`
|
||
- **2023-04-12** Returned to the Senate with amendments `receipt`
|
||
- **2023-04-13** Motion to dissent filed `filing`
|
||
- **2023-04-13** Senate dissented from House amendments
|
||
- **2023-04-18** House conferees appointed: Carbaugh and Shackleford
|
||
- **2023-04-18** House advisors appointed: Barrett, Lehman, Schaibley and Porter
|
||
- **2023-04-19** Senate conferees appointed: Charbonneau and Breaux
|
||
- **2023-04-19** Senate advisors appointed: Melton and Bohacek
|
||
- **2023-04-27** Representative Schaibley removed as advisor
|
||
- **2023-04-27** Representative Carbaugh removed as conferee
|
||
- **2023-04-27** Representative Schaibley added as conferee
|
||
- **2023-04-27** CCR # 1 filed in the Senate `filing`
|
||
- **2023-04-27** CCR # 1 filed in the House `filing`
|
||
- **2023-04-27** Rules Suspended. Conference Committee Report 1: adopted by the House; Roll Call 550: yeas 72, nays 21
|
||
- **2023-04-27** Rules Suspended. Conference Committee Report 1: adopted by the Senate; Roll Call 525: yeas 40, nays 9
|
||
- **2023-04-27** Senator Johnson removed as coauthor
|
||
- **2023-04-28** Signed by the President Pro Tempore `passage`
|
||
- **2023-04-28** Signed by the President of the Senate `passage`
|
||
- **2023-05-01** Signed by the Speaker `passage`
|
||
- **2023-05-04** Public Law 166 `became-law`
|
||
- **2023-05-04** Signed by the Governor `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/89871f11-3d5a-4b95-ad2d-86d752a9e5ac`. Confidence: reported (aggregated from official Indiana legislature records).
|
||
|